Literature DB >> 7619355

Changes of vascular architecture independent of blood pressure in experimental uremia.

K Amann1, R Neusüss, E Ritz, T Irzyniec, G Wiest, G Mall.   

Abstract

Striking alterations of the structure of arterial vessels of different caliber are a well-known feature of renal failure, but it is currently unknown to what extent they are a reflection of hypertension or of uremia per se. To address this issue further we studied subtotally nephrectomized rats, sham-operated and pair-fed with matched controls. After uremia of 14 days' duration, stereologic measurements were carried out on perfusion-fixed tissue. To eliminate a potential influence of hypertension, subgroups of animals received furosemide and hydralazine in the drinking fluid to yield daily doses of 15 mg/kg and 20 mg/kg, respectively. At the end of the experiment, systolic blood pressure (tail plethysmography) was 110 +/- 13.3 (mean +/- SD) mm Hg and 99.4 +/- 8.1 mm Hg in untreated and treated controls, respectively, and 132 +/- 20.7 mm Hg and 103 +/- 13.0 mm Hg in untreated and treated uremic animals, respectively (n = 5 to 10 animals per group). The wall:lumen ratio of intramyocardial small arteries was 0.056 +/- 0.011 and 0.052 +/- 0.006 in untreated and treated controls, respectively. In untreated and treated uremic animals, the corresponding values were 0.077 +/- 0.011 and 0.066 +/- 0.007 (P < .01; control v uremia, ANOVA). A similar increase, unaffected by blood pressure treatment, was found for wall thickness of intramyocardial arteries. Analogous changes were also noted in mesenteric arterioles and veins. Finally, aorta media thickness was significantly (P < .005) higher in uremic animals than in controls (138 +/- 29 micrometers v 103 +/- micrometers).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7619355     DOI: 10.1016/0895-7061(94)00248-a

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  21 in total

1.  Insulin resistance and left ventricular mass in non-diabetic hemodialysis patients.

Authors:  Sebnem Karakan; Siren Sezer; F Nurhan Ozdemir Acar
Journal:  Curr Ther Res Clin Exp       Date:  2012-12

Review 2.  Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.

Authors:  Suree Lekawanvijit; Henry Krum
Journal:  J Physiol       Date:  2014-06-06       Impact factor: 5.182

3.  Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.

Authors:  Navkaranbir S Bajaj; Amitoj Singh; Wunan Zhou; Ankur Gupta; Kana Fujikura; Christina Byrne; Hendrik J Harms; Michael T Osborne; Paco Bravo; Efstathia Andrikopolou; Sanjay Divakaran; Courtney F Bibbo; Jon Hainer; Hicham Skali; Viviany Taqueti; Michael Steigner; Sharmila Dorbala; David M Charytan; Sumanth D Prabhu; Ron Blankstein; Rahul C Deo; Scott D Solomon; Marcelo F Di Carli
Journal:  Circulation       Date:  2019-11-29       Impact factor: 29.690

4.  NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy.

Authors:  Philipp Kalk; Michael Godes; Katharina Relle; Christiane Rothkegel; Andreas Hucke; Johannes-Peter Stasch; Berthold Hocher
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

5.  Thallium-201 washout rate of stress myocardial perfusion imaging as a predictor of mortality in diabetic kidney disease patients initiating hemodialysis: an observational, follow-up study.

Authors:  Toshihide Hayashi; Nobuhiko Joki; Yuri Tanaka; Masaki Iwasaki; Shun Kubo; Ai Matsukane; Yasunori Takahashi; Yoshihiko Imamura; Koichi Hirahata; Hiroki Hase
Journal:  Clin Exp Nephrol       Date:  2017-04-21       Impact factor: 2.801

6.  Prognostic value of left ventricular dyssynchrony evaluated by gated myocardial perfusion imaging in patients with chronic kidney disease and normal perfusion defect scores.

Authors:  Hiroaki Mori; Satoshi Isobe; Susumu Suzuki; Kazumasa Unno; Ryota Morimoto; Naoaki Kano; Takahiro Okumura; Yoshinari Yasuda; Katsuhiko Kato; Toyoaki Murohara
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

7.  Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.

Authors:  Masato Nishimura; Toshihiko Ono
Journal:  J Nucl Cardiol       Date:  2008-09-16       Impact factor: 5.952

8.  The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions.

Authors:  Olga Laur; Meredith A Brisco; Alexander J Kula; Susan J Cheng; Abeel A Mangi; Lavanya Bellumkonda; Daniel L Jacoby; Steven Coca; W H Wilson Tang; Chirag R Parikh; Jeffrey M Testani
Journal:  J Card Fail       Date:  2015-11-23       Impact factor: 5.712

Review 9.  Aortic stiffness, kidney disease, and renal transplantation.

Authors:  Sola Aoun Bahous; Jacques Blacher; Michel E Safar
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

10.  Cystatin C associates with arterial stiffness in older adults.

Authors:  Magdalena Madero; Christina L Wassel; Carmen A Peralta; Samer S Najjar; Kim Sutton-Tyrrell; Linda Fried; Robert Canada; Anne Newman; Michael G Shlipak; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.